🔎 Trials Near Me

Utama › Penyakit Sel Sabit › Illinois › Chicago

Kajian klinikal Penyakit Sel Sabit di Chicago, IL

18 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Mengambil pesertaFasa 1
  • University of Illinois at Chicago College of Medicine, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT04055818

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Mengambil pesertaFasa 3
  • Uni of Illinois Hospital and HSC, Chicago
Umur 12 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Mengambil pesertaFasa 1
  • University of Illinois Hospital and Health Sciences System, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Mengambil pesertaFasa 3
  • Univer Of Illinois at Chicago, Chicago
Umur 2 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Mengambil pesertaFasa 3
  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06612268

Tocilizumab for Acute Chest Syndrome

Mengambil pesertaFasa 2
  • University of Chicago, Chicago
Umur 12 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05640271

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
  • Local Institution - 0034, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Mengambil pesertaFasa 2/3
  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
Umur 12 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Mengambil pesertaKajian pemerhatian
  • Rush University Medical Center, Chicago
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Mengambil pesertaFasa 2
  • University of Illinois at Chicago, Chicago
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Mengambil pesertaFasa 3
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Umur 10 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Mengambil pesertaFasa 2
  • University of Illinois at Chicago, Chicago
Umur 16 hingga 60 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Mengambil pesertaKajian pemerhatian
  • Comer Children's Hospital (MRD-HCT), Chicago
Umur 3 hingga 20 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06941389

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Mengambil pesertaFasa 2
  • University of Illinois Chicago, Sickle Cell Center, Chicago
Umur 18 hingga 60 · Semua jantina · Dikemas kini 19 Mei 2026 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Mengambil peserta
  • University of Illinois at Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Mac 2026 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Mengambil pesertaFasa 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 2 hingga 25 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Mengambil peserta
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 16 hingga 30 · Semua jantina · Dikemas kini 7 Jan 2026 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Mengambil pesertaKajian pemerhatian
  • University of Illinois, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jun 2025 · NCT06385886

Kajian Penyakit Sel Sabit di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.